US Drug Recall Register
Class II · Moderate risk Terminated Initiated Nov 6, 2013 (13 years ago)

Sumatriptan Succinate Injection, 6 mg, 0.5 mL For subcutaneous injection only, Rx only, 2…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Assurance of Sterility: A small number of pre-filled syringes may contain needles which protrude through the needle shield.

What was recalled

Sumatriptan Succinate Injection, 6 mg, 0.5 mL For subcutaneous injection only, Rx only, 2 Single-Dose Syringe Cartridges for use with sumatriptan Autoinjector Pen, Manufactured by GlaxoSmithKline, Research Triangle Park, NC 27709 for Sandoz Inc., Princeton, NJ 08540, Made in Singapore, NDC 0781-3173-07.

Recalling firm
GlaxoSmithKline, LLC.
NDC code
0781-3173-07
Origin
NC, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-388-2014

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Sumatriptan recalls

See all